Chakra Biotech is a Contract Research Organisation (CRO) meeting the growing needs of pharma and biotech companies for better ways of assessing their discovery stage psychiatric compounds. We model the efficacy of discovery compounds to predict human efficacy, ensuring the compounds taken forward to preclinical testing are the ones most likely to be effective once they are in clinical trials.